Ribonucleic Acid (RNA) Sequencing Global Market Report 2025
상품코드:1825897
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
리보핵산(RNA) 시퀀싱 시장 규모는 향후 몇 년 동안 비약적인 성장이 예상됩니다. 2029년에는 CAGR 20.5%로 83억 4,000만 달러로 성장할 것입니다. 예측 기간의 성장은 신속하고 정확한 질병 진단에 대한 수요 증가, 실시간 중합효소 연쇄 반응의 채택 확대, 신속한 현장 진단 검사에 대한 수요 증가, 감염성 질환 발생 증가, 동반진단 약품에 대한 수요 증가에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 질병 탐지 및 모니터링, 신약 개발, 표적 검증, 바이오마커 식별, DNA 시퀀싱 기술, 진단 검사 발전, 차세대 시퀀싱(NGS), 미세유체공학, 랩온칩 플랫폼, 첨단 분자진단 솔루션 개발 등이 있습니다.
향후 5년간 20.5%의 성장률 전망은 지난번 예측보다 1.8% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 싱가포르와 스웨덴에서 개발된 리보핵산(RNA) 시퀀싱 키트와 시퀀싱 시약의 가격을 급등시켜 암 프로파일링의 지연과 병리 검사 비용의 상승을 가져와 미국의 정밀 암 진단의 채택을 방해할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
리보핵산(RNA) 시퀀싱 시장의 성장 궤적은 정밀의료에 대한 관심이 높아짐에 따라 촉진될 것으로 예상됩니다. 맞춤형 의료라고도 불리는 정밀의료는 유전자, 환경, 라이프스타일의 개인차를 고려한 치료와 예방에 대한 혁신적인 접근 방식입니다. 이러한 접근법은 유전체학의 발전, 질병의 복잡성, 지원적인 규제 조치에 힘입어 더욱 효과적인 치료를 제공할 수 있을 것으로 기대됩니다. RNA 시퀀싱 기술은 이러한 상황에서 중요한 역할을 하며, RNA 분자의 염기서열 분석과 시료 내 발현 수준을 정량화할 수 있게 합니다. 이러한 기술은 전사체의 종합적인 분석을 용이하게 하고, 유전자 발현 패턴, 대체 스플라이싱 이벤트, RNA 변형에 대한 인사이트를 제공합니다. 주목할 만한 것은 FDA가 2024년 2월 희귀질환 환자를 위한 16개의 새로운 개별화 치료제를 승인했다는 점입니다. 그 결과, 정밀의료에 대한 관심이 높아지면서 리보핵산(RNA) 시퀀싱 시장 확대의 원동력이 되고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 리보핵산(RNA) 시퀀싱 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 리보핵산(RNA) 시퀀싱 시장 : 성장률 분석
세계의 리보핵산(RNA) 시퀀싱 시장 실적 : 규모와 성장, 2019-2024
세계의 리보핵산(RNA) 시퀀싱 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 리보핵산(RNA) 시퀀싱 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 리보핵산(RNA) 시퀀싱 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
기기
시약과 키트
소프트웨어
세계의 리보핵산(RNA) 시퀀싱 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
단일 분자 기반 시퀀싱
시켄스바이신세시스테크노로지
나노포어 시퀀싱 기술
이온 토렌트 반도체 시퀀싱
세계의 리보핵산(RNA) 시퀀싱 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
진단
Drug Discovery
트란스레이쇼나르메디신
기타 용도
세계의 리보핵산(RNA) 시퀀싱 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
조사와 학술
병원과 진료소
제약 및 바이오테크놀러지 기업
기타 최종사용자
세계의 리보핵산(RNA) 시퀀싱 시장 : 하위 세분화 기기 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
차세대 시퀀싱
마이크로어레이 기기
단일세포 RNA 시퀀싱 장비
세계의 리보핵산(RNA) 시퀀싱 시장 : 하위 세분화 시약과 키트(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
RNA 추출 키트
RNA 시퀀싱 키트
도서관 준비 키트
세계의 리보핵산(RNA) 시퀀싱 시장 : 하위 세분화 소프트웨어(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
데이터 분석 소프트웨어
데이터 관리 소프트웨어
바이오인포매틱스 소프트웨어
제7장 지역별·국가별 분석
세계의 리보핵산(RNA) 시퀀싱 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 리보핵산(RNA) 시퀀싱 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
리보핵산(RNA) 시퀀싱 시장 : 경쟁 구도
리보핵산(RNA) 시퀀싱 시장 : 기업 개요
F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
GE HealthCare Technologies Inc
Eurofins Scientific SE
Agilent Technologies Inc
Illumina Inc
PerkinElmer Inc
bioMerieux SA
Beckman Coulter Inc
Sysmex Corporation
Bio-Rad Laboratories Inc
QIAGEN N.V.
Tecan Genomics Inc
Natera Inc
Myriad Genetics Inc.
BGI Genomics Co Ltd
Takara Bio Inc
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
리보핵산(RNA) 시퀀싱 시장 2029 : 새로운 기회를 제공하는 국가
리보핵산(RNA) 시퀀싱 시장 2029 : 새로운 기회를 제공하는 부문
리보핵산(RNA) 시퀀싱 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
RNA sequencing, employing next-generation sequencing techniques, unveils the presence and abundance of RNA molecules within a biological specimen, offering a glimpse into gene expression dynamics. This methodology empowers scientists to delve into gene expression patterns, unearth novel transcripts, and decipher RNA processing mechanisms.
Within the realm of ribonucleic acid (RNA) sequencing, the primary product categories comprise instruments, reagents and kits, and software. Instruments encompass the tangible apparatuses utilized for RNA molecule analysis, encompassing sequencers and polymerase chain reaction devices, pivotal for accurate RNA sample processing and examination. Diverse technologies, including single molecule-based sequencing, sequence by synthesis, nanopore sequencing, and ion torrent semiconductor sequencing, find application across various sectors such as diagnostics, drug discovery, and translational medicine. End-users span research and academia, hospitals and clinics, pharmaceutical and biotechnology firms, among others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The ribonucleic acid (RNA) sequencing market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (RNA) sequencing market statistics, including ribonucleic acid (RNA) sequencing industry global market size, regional shares, competitors with a ribonucleic acid (RNA) sequencing market share, detailed ribonucleic acid (RNA) sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (RNA) sequencing industry. This ribonucleic acid (RNA) sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ribonucleic acid (rna) sequencing market size has grown exponentially in recent years. It will grow from $3.25 billion in 2024 to $3.96 billion in 2025 at a compound annual growth rate (CAGR) of 21.8%. The growth in the historic period can be attributed to rising number of drug development activities, growing prevalence of genetic disorders and target diseases, increasing use of miniaturized portable instruments, growing use of biomarker profiling, growing demand for personalized medicine, and the increasing number of cancer patients.
The ribonucleic acid (rna) sequencing market size is expected to see exponential growth in the next few years. It will grow to $8.34 billion in 2029 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to rise in demand for rapid and accurate diagnosis of disease, growing adoption of real-time polymerase chain reaction, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and demand for companion diagnostics. Major trends in the forecast period include disease detection and monitoring, drug discovery, target validation, biomarker identification, DNA sequencing technologies, diagnostic testing advancements, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and advanced molecular diagnostic solutions development.
The forecast of 20.5% growth over the next five years reflects a modest reduction of 1.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of precision oncology diagnostics by inflating prices of Ribonucleic Acid (RNA) Sequencing extraction kits and sequencing reagents developed in Singapore and Sweden, resulting in slower cancer profiling and higher pathology lab costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growth trajectory of the ribonucleic acid (RNA) sequencing market is expected to be propelled by an increasing emphasis on precision medicine. Precision medicine, also known as personalized medicine, represents an innovative approach to medical treatment and prevention, taking into account individual variability in genes, environment, and lifestyle. This approach holds promise for offering more effective treatments, spurred by advancements in genomics, the rising complexity of diseases, and supportive regulatory measures. RNA sequencing technologies play a crucial role in this landscape, enabling the determination of RNA molecule sequences and quantification of their expression levels within samples. Such technologies facilitate comprehensive analysis of transcriptomes, offering insights into gene expression patterns, alternative splicing events, and RNA modifications. Notably, in February 2024, the FDA approved 16 novel personalized therapies for patients with rare diseases, compared to six approvals in 2022, as reported by the Personalized Medicine Coalition. Consequently, the growing focus on precision medicine serves as a driving force behind the ribonucleic acid (RNA) sequencing market's expansion.
In the ribonucleic acid (RNA) sequencing market, key players prioritize RNA next-generation sequencing assays to enhance patient care through data-driven insights and precision medicine. RNA next-generation sequencing assays leverage advanced genomic sequencing technologies to analyze a patient's entire exome, representing a next-generation exome sequencing platform. For example, in June 2023, Tempus, a US-based precision medicine technology company, introduced its new standalone RNA next-generation sequencing assay, Tempus xR. This innovative assay, tailored for solid tumors, provides a comprehensive analysis of the entire transcriptome, identifying clinically significant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This offering caters to physicians with specific interests in RNA fusions or altered splicing, as well as to providers, researchers, and biopharma companies seeking detailed RNA sequencing analysis for their existing samples.
In January 2024, Parse Biosciences, a US-based biotechnology company focusing on developing innovative solutions for biological research and diagnostics, completed the acquisition of Biomage for an undisclosed sum. This acquisition enables Parse Biosciences to integrate Biomage's robust data analysis tools, including its Cellenics cloud-based platform, into Parse's Evercode combinatorial barcoding technology. Biomage Ltd., based in the UK, specializes in RNA sequencing and analysis software and services.
Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc, Eurofins Scientific SE, Agilent Technologies Inc, Illumina Inc, PerkinElmer Inc, bioMerieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN N.V., Tecan Genomics Inc, Natera Inc, Myriad Genetics Inc., BGI Genomics Co Ltd, Takara Bio Inc, Cepheid, NeoGenomics Laboratories Inc, Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc, Macrogen Inc, Standard BioTools Inc, Ambry Genetics Corporation, Biocartis SA, CD Genomics.
North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ribonucleic acid (RNA) sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ribonucleic acid (RNA) sequencing market consists of revenues earned by entities by providing services such as library preparation, RNA extraction, fragmentation, reverse transcription, adapter ligation, sequencing, data analysis, bioinformatics support, consultation and experimental design, quality control, sample preparation services, gene cloning, genotyping and mutation detection, and pathogen detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA) sequencing market also includes sales of library preparation kits, RNA extraction kits, quantification kits, polymerase chain reaction (PCR) instruments, pipette tips, tubes, and plates. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ribonucleic Acid (RNA) Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ribonucleic acid (rna) sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for ribonucleic acid (rna) sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) sequencing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Instruments; Reagents And Kits; Software
2) By Technology: Single Molecule Based Sequencing; Sequence By Synthesis Technology; Nanopore Sequencing Technology; Ion Torrent Semiconductor Sequencing
3) By Applications: Diagnostics; Drug Discovery; Translational Medicine; Other Applications
4) By End User: Research And Academia; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
3. Ribonucleic Acid (RNA) Sequencing Market Trends And Strategies
4. Ribonucleic Acid (RNA) Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Ribonucleic Acid (RNA) Sequencing Growth Analysis And Strategic Analysis Framework
5.1. Global Ribonucleic Acid (RNA) Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Ribonucleic Acid (RNA) Sequencing Market Growth Rate Analysis
5.4. Global Ribonucleic Acid (RNA) Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Ribonucleic Acid (RNA) Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Ribonucleic Acid (RNA) Sequencing Total Addressable Market (TAM)
6.1. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instruments
Reagents And Kits
Software
6.2. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Molecule Based Sequencing
Sequence By Synthesis Technology
Nanopore Sequencing Technology
Ion Torrent Semiconductor Sequencing
6.3. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostics
Drug Discovery
Translational Medicine
Other Applications
6.4. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research And Academia
Hospitals And Clinics
Pharmaceutical And Biotechnology Companies
Other End Users
6.5. Global Ribonucleic Acid (RNA) Sequencing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencers
Microarray Instruments
Single-Cell Rna Sequencing Instruments
6.6. Global Ribonucleic Acid (RNA) Sequencing Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rna Extraction Kits
Rna Sequencing Kits
Library Preparation Kits
6.7. Global Ribonucleic Acid (RNA) Sequencing Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Analysis Software
Data Management Software
Bioinformatics Software
7. Ribonucleic Acid (RNA) Sequencing Market Regional And Country Analysis
7.1. Global Ribonucleic Acid (RNA) Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Ribonucleic Acid (RNA) Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Ribonucleic Acid (RNA) Sequencing Market
9.1. China Ribonucleic Acid (RNA) Sequencing Market Overview
9.2. China Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Ribonucleic Acid (RNA) Sequencing Market
10.1. India Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Ribonucleic Acid (RNA) Sequencing Market
11.1. Japan Ribonucleic Acid (RNA) Sequencing Market Overview
11.2. Japan Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Ribonucleic Acid (RNA) Sequencing Market
12.1. Australia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Ribonucleic Acid (RNA) Sequencing Market
13.1. Indonesia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Ribonucleic Acid (RNA) Sequencing Market
14.1. South Korea Ribonucleic Acid (RNA) Sequencing Market Overview
14.2. South Korea Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Ribonucleic Acid (RNA) Sequencing Market
15.1. Western Europe Ribonucleic Acid (RNA) Sequencing Market Overview
15.2. Western Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Ribonucleic Acid (RNA) Sequencing Market
16.1. UK Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market
21.1. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market Overview
21.2. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Ribonucleic Acid (RNA) Sequencing Market
22.1. Russia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Ribonucleic Acid (RNA) Sequencing Market
23.1. North America Ribonucleic Acid (RNA) Sequencing Market Overview
23.2. North America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Ribonucleic Acid (RNA) Sequencing Market
24.1. USA Ribonucleic Acid (RNA) Sequencing Market Overview
24.2. USA Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Ribonucleic Acid (RNA) Sequencing Market
26.1. South America Ribonucleic Acid (RNA) Sequencing Market Overview
26.2. South America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Ribonucleic Acid (RNA) Sequencing Market
27.1. Brazil Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Ribonucleic Acid (RNA) Sequencing Market
28.1. Middle East Ribonucleic Acid (RNA) Sequencing Market Overview
28.2. Middle East Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Ribonucleic Acid (RNA) Sequencing Market
29.1. Africa Ribonucleic Acid (RNA) Sequencing Market Overview
29.2. Africa Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Ribonucleic Acid (RNA) Sequencing Market Competitive Landscape And Company Profiles
